Low-T drugs marketed to help men get their mojo back are having a moment, but are they safe?
With the market for low-testosterone, or “Low-T,” therapy projected to reach $5 billion by 2017, many new centers have sprung up across the country offering a spectacular catch-all treatment.
TIME spoke to experts in the field and visited the Ageless Men’s Health testosterone clinic to get the inside story on a treatment that promises to “boost your strength training, sex drive and performance to the levels you’ve been wanting.”
Read TIME’s cover story, “Manopause?! Aging, Insecurity and the $2 Billion Testosterone Industry,” here.
Phillip Toledano for TIME
More Must-Read Stories From TIME
- Employers Take Note: Young Workers Are Seeking Jobs with a Higher Purpose
- Signs Are Pointing to a Slowdown in the Housing Market—At Last
- Welcome to the Era of Unapologetic Bad Taste
- As the Virus Evolves, COVID-19 Reinfections Are Going to Keep Happening
- A New York Mosque Becomes a Refuge for Afghan Teens Who Fled Without Their Families
- High Gas Prices are Oil Companies' Fault says Ro Khanna, and Democrats Should Go After Them
- Two Million Cases: COVID-19 May Finally Force North Korea to Open Up
Read More From TIME
